SCHEMBL1873078

SCHEMBL1873078

CCN(c1ccc2ccccc2c1)c1nc(N)nc(-c2ccc(C[C@H](N)C(=O)O)cc2)n1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TPH1 P17752 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1872985 0.92 TPH1 (0.56) TPH1
SCHEMBL27809408 0.87 TPH1 (0.61) TPH1
SCHEMBL1131296 0.87 TPH1 (0.61) TPH1
SCHEMBL1869997 0.87 TPH1 (0.61) TPH1
SCHEMBL1877770 0.85 TPH1 (0.49) TPH1
SCHEMBL1768159 0.85 TPH1 (0.53) TPH1
SCHEMBL1869970 0.85 TPH1 (0.51) TPH1
SCHEMBL1129387 0.83 TPH1 (0.58) TPH1
SCHEMBL1880942 0.79 TPH1 (0.49) TPH1
SCHEMBL1129122 0.79 TPH1 (0.49) TPH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496231-A1 TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF CANCER Lexicon Pharmaceuticals, Inc. (US) 2012-09-12 EP disclosed
WO-2011056916-A1 TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF CANCER LEXICON PHARMACEUTICALS, INC. (US) 2011-05-12 WO disclosed